Previous 10 | Next 10 |
2023-07-13 17:00:40 ET Summary QuidelOrtho, a result of a 2022 business combination, was a strong player in the COVID-19 testing sector, generating $1.3 billion in 2021 from COVID products. The company experienced a dramatic drop in share prices in early 2022, with shares trading ...
2023-07-13 02:31:44 ET Summary QuidelOrtho Corporation's Sofia 2 SARS Antigen+ FIA, the first rapid antigen test that detects Covid-19, was approved by the FDA in March 2023. Despite strong cash flows and a 13% FCF margin, QuidelOrtho's long-term debts have grown from 0 - $2.4 bil...
2023-06-06 03:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-27 12:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostics technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that members of its management team are scheduled to participate i...
2023-05-11 07:20:32 ET Free at-home COVID-19 tests will still be accessible via mail for Americans until the end of May even as the Public Health Emergency (PHE) is set to conclude on Thursday officially, the Biden administration announced this week. Since the government launched the pr...
2023-05-04 14:28:34 ET A panel of experts at the World Health Organization (WHO) is expected to meet on Thursday to discuss whether the current COVID-19 pandemic will remain a global emergency, the U.N. agency's highest alert level. The head of the WHO, Dr. Tedros Adhanom Ghebreyesus, i...
2023-05-03 20:38:05 ET QuidelOrtho Corporation (QDEL) Q1 2023 Earnings Conference Call May 03, 2023 05:00 PM ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Douglas Bryant - President and Chief Executive Officer Joseph Busky - Chief...
2023-05-03 16:42:06 ET Quidel press release ( NASDAQ: QDEL ): Q1 Non-GAAP EPS of $1.80 beats by $0.37 . Revenue of $846.1M (-15.4% Y/Y) beats by $73.94M . Growth in non-respiratory revenue for the first quarter was driven by the Labs business unit, primarily du...
Highlights First quarter revenue of $846.1 million decreased by 16% as reported with non-respiratory revenue up 5% on a supplemental combined basis (up 7% in constant currency) and respiratory revenue down 72% on a supplemental combined basis Growth in non-respiratory revenue for th...
News, Short Squeeze, Breakout and More Instantly...
Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 PR Newswire NEW YORK , July 23, 2024 /PRNewswir...
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will report its financ...
2024-07-09 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...